XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Cash Flow Statements (Unaudited) (USD $)
 9 Months Ended
Sep. 29, 2013
Sep. 30, 2012
Cash flows from operating activities:    
Net (loss) income $ (9,948,000) $ 3,987,000
Loss from discontinued operations 0 (7,130,000)
(Loss) income from continuing operations (9,948,000) 11,117,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 9,355,000 9,141,000
Gain on sale of marketable securities 0 (1,850,000)
Stock-based compensation expense 1,452,000 1,331,000
Deferred revenue recognized (6,000,000) (5,919,000)
Deferred loan costs recognized 58,000 58,000
Gain on sale of assets (1,645,000) (2,625,000)
Provision for excess and obsolete inventory 1,021,000 629,000
Goodwill impairment 6,900,000 0
Other noncash items 549,000 1,514,000
Contributions to pension plans (477,000) (1,312,000)
Change in operating assets and liabilities:    
Accounts receivable (7,931,000) (887,000)
Inventory (4,656,000) (3,035,000)
Prepaid expenses and other assets 535,000 (638,000)
Accounts payable 9,888,000 (5,507,000)
Accrued and other liabilities 31,000 (930,000)
Net cash (used in) provided by operating activities (868,000) 1,087,000
Cash flows from investing activities:    
Capital expenditures, net (3,092,000) (4,106,000)
Proceeds from sale of marketable securities 0 1,271,000
Proceeds from sale of assets 2,265,000 4,542,000
Net cash (used in) provided by investing activities (827,000) 1,707,000
Cash flows from financing activities:    
Net change in debt under revolving credit agreements (5,974,000) (2,000,000)
Common stock repurchases (9,000) (575,000)
Indirect repurchase of shares for minimum statutory tax withholdings (565,000) (511,000)
Cash dividends paid (808,000) (801,000)
Proceeds from the issuance of common stock 0 1,000
Net cash used in financing activities (7,356,000) (3,886,000)
Net decrease in cash and cash equivalents (9,051,000) (1,092,000)
Cash and cash equivalents at beginning of period 18,664,000 18,173,000
Cash and cash equivalents at end of period $ 9,613,000 $ 17,081,000